GPP
GBIO

Great Point Partners’s Generation Bio GBIO Stock Holding History

Great Point Partners’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-102,254
Closed -$3.88M – 39
2023
Q3 		$3.88M Hold
102,254
– – 0.71% 36
2023
Q2 		$5.62M Hold
102,254
– – 1.1% 28
2023
Q1 		$4.4M Hold
102,254
– – 0.86% 29
2022
Q4 		$4.02M Buy
102,254
+19,746
+24% +$1.04M 0.79% 38
2022
Q3 		$4.38M Buy
+82,508
New +$5.16M 1.05% 26

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Great Point Partners's GBIO Position: Q4 2023 in Review

Great Point Partners sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 102,254 shares — an estimated $3.88M sold.

Great Point Partners first reported a position in GBIO in Q3 2022 and held it in 5 quarters. The position peaked at $5.62M in Q2 2023. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • Great Point Partners reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • Great Point Partners sold 102,254 Generation Bio shares in Q4 2023, an estimated $3.88M.
  • Great Point Partners first reported a position in Generation Bio in Q3 2022 and held it in 5 quarters.
  • Great Point Partners's Generation Bio position peaked at $5.62M in Q2 2023.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on Great Point Partners's 13F filing for Q4 2023, filed 14 Feb 2024.